The Association between Interleukin-6 and Mean Platelet Volume Levels in Central Obesity with or without Non-Alcoholic Fatty Liver Disease

Authors

  • Linda Rotty Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine Sam Ratulangi University/ Prof dr. R.D. Kandou Hospital, Manado
  • Nelly Tendean Division of Gastroentero-Hepatology, Department of Internal Medicine, Faculty of Medicine Sam Ratulangi University/ Prof dr. R.D. Kandou Hospital, Manado, Indonesia
  • Nancy Lestari Department of Internal Medicine, Faculty of Medicine Sam Ratulangi University/Prof dr. R.D. Kandou Hospital, Manado
  • Randy Adiwinata Faculty of Medicine, Atmajaya Catholic University, Jakarta

DOI:

https://doi.org/10.24871/2132020193-198

Keywords:

Interleukin-6, mean platelet volume, non alcoholic fatty liver disease, central obesity

Abstract

Background: Obesity had become a global problem today. Obesity is a significant risk factor of cardiovascular and other metabolic diseases such as non-alcoholic fatty liver disease (NAFLD). It remains unclear if the increased mean platelet volume (MPV) at the steatosis state is practicable as early detection of the occurrence of fatty liver in individuals with central obesity. This study aims to determine the association of interleukin-6 (IL-6) and MPV levels in central obesity with or without NAFLD.

Method: This study was descriptive-analytic with a cross-sectional approach conducted in Prof. dr. R. D. Kandou Manado general hospital from May to July 2018. Consecutive sampling was performed based on inclusion criteria, then IL-6, MPV, and abdominal ultrasound examinations were performed.

Results: This study included 40 samples of men with central obesity, 28 people (70%) among them were diagnosed with NAFLD. The Fisher exact test showed an association between NAFLD and an increase in IL-6 (p = 0.039), also between MPV and NAFLD (p=0.015). Pearson correlation test showed there was no significant correlation between IL-6 and MPV in the NAFLD sample group (p = 0.084; r -0.332) and in the non-NAFLD sample group (p = 0.564; r -0.186).

Conclusion: Elevated MPV and IL-6 values may be used as marker for NAFLD presence among central obesity patients.

Downloads

Published

2020-12-30

How to Cite

Rotty, L., Tendean, N., Lestari, N., & Adiwinata, R. (2020). The Association between Interleukin-6 and Mean Platelet Volume Levels in Central Obesity with or without Non-Alcoholic Fatty Liver Disease. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 21(3), 193–198. https://doi.org/10.24871/2132020193-198

Issue

Vol. 21 No. 3 (2020): VOLUME 21, NUMBER 3, December 2020

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).